Other four laboratories to conduct COVID-19 vaccine clinical trials in Peru

Photo: ANDINA/Diffusion

Photo: ANDINA/Diffusion

15:40 | Lima, Sep. 24.

Four international laboratories —which are developing vaccines against COVID-19— get ready to start their clinical trials in Peru, thus adding to the studies already carried out by China's Sinopharm, Immunization Advisor at the Health Ministry (Minsa) Carlos Castillo reported on Thursday.

The arrival of international laboratory researchers will allow Peru to rely on greater assurance that the vaccine will work for its population, he said.

According to the official, the country —at the same time— has a system which guarantees the safety of clinical trials.

Castillo added that an Ethics Committee has been formed at Minsa, which approves and monitors the tests, while the General Directorate of Medicines, Supplies and Drugs (Digemid) ensures quality and safety, and the National Health Institute (INS) works on the corresponding administrative affairs.

German laboratory CureVac is expected to start its clinical trials in Lima in November.

For its part, the Imperial College of the United Kingdom plans to carry out its tests in Lima and Moquegua from January 2021.

Lastly, Castillo indicated that other laboratories could join this list in the coming days.


Published: 9/24/2020
Most read